Abstract
The PRIAMO study is a cross-sectional longitudinal observational study aimed at describing epidemiology and evolution of non-motor symptoms (NMS) in patients with different forms of parkinsonism recruited in 55 Italian centres and evaluated over 24 months. In this paper, we are reporting prevalence and clinical characteristics of NMS in patients with atypical and secondary parkinsonism. Out of 1307 consecutive patients with a diagnosis of parkinsonism, 83 patients had vascular parkinsonism (VP), 34 had multiple system atrophy (MSA), 30 had progressive supranuclear palsy (PSP), 14 had dementia with Lewy bodies (DLB) and 11 had corticobasal degeneration (CBD). MSA and DLB had the highest number of NMS domains and symptoms, respectively. Gastrointestinal symptoms, pain, urinary problems and postural instability due to orthostatic hypotension were most frequent in MSA. Sleep disturbances were also common with a prevalence of approximately 70% in all diagnostic groups but CBD (36%). Psychiatric symptoms and attention and memory impairment were frequently observed in all diagnoses but were most prevalent among DLB patients, whereas the prevalence of skin and respiratory disorders was rather low in all forms, ranging between 10 and 30%. Atypical parkinsonism patients also reported a low QoL, with no significant differences among the different forms, whereas PD and VP patients had a better QoL.
Similar content being viewed by others
References
Antonini A, Colosimo C, Marconi R, Morgante L, Barone P (2008) The PRIAMO Study: background, methods and recruitment. Neurol Sci 2:61–65
Appollonio I, Leone M, Isella V et al (2005) The Frontal Assessment Battery (FAB): normative values in an Italian population sample. Neurol Sci 26:108–116
Bensimon G, Ludolph A, Agid Y, Vidailhet M, Payan C, Leigh PN (2009) NNIPPS Study Group Riluzole treatment, survival and diagnostic criteria in Parkinson plus disorders: the NNIPPS study. Brain 132:156–171
Chaudhuri KR, Healy DG, Schapira A (2006) Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurol 5:235–245
Colosimo C, Geser F, Benarroch EE, Wenning GK (2007) Multiple system atrophy. In: Gilman S (ed) Neurobiology of disease. Academic Press, CA, pp 200–202
Colosimo C, Tiple D, Berardelli A (2008) Clinical differential diagnosis of parkinsonism. Future Neurol 3:287–298
Dubois B, Slachevsky A, Litvan I et al (2000) The FAB: a Frontal Assessment Battery at bedside. Neurology 55:1621–1626
Fahn S, Elton R, Members of the UPDRS Development Committee (1987) The Unified Parkinson’s Disease Rating Scale. In: Fahn S, Marsden CD, Calne DB, Goldstein M, eds. Recent developments in Parkinson’s disease, vol 2. Macmillan Health Care Information, Florham Park, pp 153–63, 293–304
Folstein MF, Folstein SE, McHugh PR (1975) “Mini-Mental State”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198
Ford B, Louise P, Greene P et al (1996) Oral and genital pain syndromes in Parkinson’s disease. Mov Disord 11:421–426
Gelb DJ, Oliver E, Gilman S (1999) Diagnostic criteria for Parkinson disease. Arch Neurol 56:33–39
Gilman S, Low PA, Quinn N et al (1999) Consensus statement on the diagnosis of multiple system atrophy. J Neurol Sci 163:94–98
Gilman S, Wenning GK, Low PA et al (2008) Second consensus statement on the diagnosis of multiple system atrophy. Neurology 71:670–676
Hamilton M (1960) A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56–62
Hoehn MM, Yahr MD (1967) Parkinsonism: onset, progression and mortality. Neurology 17:427–442
Litvan I (2005) Atypical Parkinsonian disorders—clinical and research aspects. Humana Press, Totowa
Litvan I (2007) Update on atypical parkinsonian disorders. Curr Opin Neurol 20:434–437
Litvan I, Agid Y, Calne D et al (1996) Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 47:1–9
Litvan I, Bhatia KP, Burn DJ et al (2003) Movement Disorders Society Scientific Issues Committee report: SIC task force appraisal of clinical diagnostic criteria for Parkinsonian disorders. Mov Disord 18:467–486
Litvan I, Campbell G, Mangone CA et al (1997) Which clinical features differentiate progressive supranuclear palsy from related disorders? A clinicopathological study. Brain 12:65–74
Mamikonyan E, Moberg PJ, Siderowf A, Duda JE, Have TT, Hurtig HI, Stern MB, Weintraub D (2009) Mild cognitive impairment is common in Parkinson’s disease patients with normal Mini-Mental State Examination (MMSE) scores. Parkinsonism Relat Disord 15:226–231
McDowell I, Newell C (1996) Measuring health: a guide to rating scales and questionnaires. Oxford University Press, New York
McKeith IG, Dickson DW, Lowe J et al (2005) Diagnosis and management of dementia with Lewy bodies: third report of the LBD consortium. Neurology 65:1863–1872
McKeith I, Mintzer J, Aarsland D et al (2004) Dementia with Lewy bodies. Lancet Neurol 3:19–28
Measso GF, Cavarzeran F, Zappalà G et al (1993) The Mini-Mental State Examination: normative study of a random sample of Italian population. Dev Neuropsychol 9:77–85
Morgante L, Rocca WA, Di Rosa AE et al (1992) Prevalence of Parkinson’s disease and other types of parkinsonism: a door-to-door survey in three Sicilian municipalities. The Sicilian Neuro-Epidemiologic Study (SNES) Group. Neurology 42:1901–1907
Müller J, Wenning GK, Jellinger K, McKee A, Poewe W, Litvan I (2000) Progression of Hoehn and Yahr stages in Parkinsonian disorders: a clinicopathologic study. Neurology 55:888–891
Peto V, Jenkinson C, Fitzpatrick R et al (1995) The development and validation of a short measure of functioning and well being for individuals with Parkinson’s disease. Qual Life Res 4:241–248
Quinn N, Koller WC, Lang AE et al (1996) Painful Parkinson’s disease. Lancet 1:1366–1369
Riley DE, Lang AE (2000) Clinical diagnostic criteria of corticobasal degeneration. Adv Neurol 82:1233–1245
Stamelou M, Reuss A, Pilatus U et al (2008) Short-term effects of coenzyme Q10 in progressive supranuclear palsy: a randomized, placebo-controlled trial. Mov Disord 23:942–949
Tison F, Wenning GK, Volonte MA et al (1996) Pain in multiple system atrophy. J Neurol 243:153–156
Tuite PJ, Krawczewski K (2007) Parkinsonism: a review-of-system approach to diagnosis. Semin Neurol 27:113–122
Wenning GK, Colosimo C, Geser F, Poewe W (2004) Multiple system atrophy. Lancet Neurol 3:93–103
Williams DR, Lees AJ (2009) Progressive supranuclear palsy: clinicopathological concepts and diagnostic challenges. Lancet Neurol 8:270–279
Zijlmans JC, Daniel SE, Hughes AJ, Révész T, Lees AJ (2004) Clinicopathological investigation of vascular parkinsonism, including clinical criteria for diagnosis. Mov Disord 19:630–640
Acknowledgments
This study was supported by an educational grant issued by Boehringer-Ingelheim, Italy. L. Simoni is an employee of Medidata s.r.l.
Author information
Authors and Affiliations
Consortia
Corresponding author
Additional information
The members of the PRIAMO study group are listed in Appendix 1.
Appendix I: The PRIAMO study group
Appendix I: The PRIAMO study group
Steering Committee:
-
Angelo Antonini—Istituti Clinici di Perfezionamento, Milano,
-
Paolo Barone—Università Federico II, Napoli,
-
Carlo Colosimo—Sapienza Università di Roma,
-
Roberto Marconi—Ospedale della Misericordia, Grosseto,
-
Letterio Morgante—Università di Messina, Italy.
Participating centres:
-
Benincasa D—Ospedale Sant’Andrea, Sapienza Università di Roma
-
Biguzzi S—Ospedale Sant’Anna, Ferrara,
-
Braga M—Ospedale Civile, Vimercate,
-
Capecci M—Ospedale Umberto I, Ancona;
-
Caravona N—Sapienza Università di Roma,
-
D’Asta G—PO Guzzardi, Vittoria,
-
De Falco FA—Ospedale S Maria Loreto Nuovo, Napoli,
-
De Gaspari D, Pezzoli G—Parkinson Institute, Istituti Clinici di Perfezionamento, Milano,
-
Di Giovanni M, Ospedale Regionale, Aosta;
-
Floris G, Clinica Neurologica, Policlinico Universitario, Monserrato,Cagliari;
-
Gallerini S, Grasso L—Ospedale della Misericordia, Grosseto,
-
Gurgone G—Azienda Ospedaliera S. Giovanni di Dio, Agrigento,
-
Kiferle L, Ospedale Santa Chiara, Pisa;
-
Meoni S—Clinica Neurologica I, Azienda Ospedaliera Universitaria, Firenze
-
Morgante F, Savica R—Università di Messina,
-
Moschella V—Policlinico Tor Vergata, Roma,
-
Pepe F—Fondazione Poliambulanza, Brescia,
-
Petretta V—AORN San Giuseppe Moscati, Avellino,
-
Randisi MG—Azienda Ospedaliera S Elia, Caltanissetta,
-
Romeno M—Ospedale Villa Sofia CTO, Palermo,
-
Santangelo G, Ianniciello M—Università Federico II, Napoli,
-
Sorbello V—Policlinico Universitario, Catania,
-
Fabbrini G, Berardelli A—Sapienza Università di Roma
-
Guidubaldi A—Università Cattolica S Cuore, Roma,
-
Muoio R—IRCCS San Raffaele, Roma,
-
Toni V—PO F Ferrari, Casarano,
-
Logi C—Ospedale Versilia, Camaiore,
-
Ciacci G, Ulivelli M—Policlinico Le Scotte, Siena,
-
Perini M, Lanfranchi S—Ospedale S Antonio Abate, Gallarate,
-
Griffini S, Troianiello B—Istituto Clinico Città di Brescia,
-
Baratti M, Amidei S—Ospedale Ramazzini, Carpi,
-
Consoli D, Iellamo M—Ospedale G Iazzolino, Vibo Valentia,
-
Cuomo T—Ospedale Civile Umberto I, Nocera Inferiore,
-
Scaglioni A, Medici D—Ospedale di Vaio, Fidenza,
-
Abbruzzese G, Di Brigida G—Università degli Studi di Genova, Genova,
-
Cocco GA, Agnetti V—Università degli Studi di Sassari, Sassari,
-
Cossu G, Deriu M—Azienda Ospedaliera G Brotzu, Cagliari,
-
Abrignani M, Modica C—Ospedale San Biagio di Marsala, Marsala,
-
Albani G, Milan E—Istituto Scientifico San Giuseppe, Piancavallo,
-
Martinelli P, Scaglione C—Università di Bologna, Bologna,
-
Mucchiut M, Zanini S—Policlinico Universitario, Udine,
-
Pennisi F—Ospedale di Castelvetrano, Castelvetrano, Trapani,
-
Soliveri P, Albanese A—Istituto Nazionale Neurologico C Besta, Milano,
-
Bartolomei L, L’erario R—Ospedale Civile San Bortolo, Vicenza,
-
Capus L, Ferigo L—Ospedale di Gattinara, Trieste,
-
Marano R, Nastasi V—Azienda Ospedaliera Papardo, Messina,
-
Luciano R, Maiello L—Ospedale Monaldi, Napoli,
-
Simone P, Fogli D—Ospedale Casa Sollievo della Sofferenza, San Giovanni Rotondo,
-
Lopiano L, Pesare M—ASO Molinette, Torino,
-
Nordera G, Pilleri E—Casa di Cura Villa Margherita, Arcugnano,
-
Scaravilli T—Azienda Ospedaliera Padova, Padova,
-
Giaccaglini E, Alesi C—Ospedale Civile, Jesi, Italy.
Sponsorship:
-
Tania Corbetta, Arina Dumitriu, Boehringer Ingelheim, Milano, Italy.
Project Management, Statistical Analyses and data management:
-
Simona Sgarbi, project leader MediData Studi e Ricerche, Modena
-
Andrea Rapisarda, clinical project manager MediData Studi e Ricerche, Modena
-
Sara Rizzoli, Lucia Simoni, statisticians MediData Studi e Ricerche, Modena
-
Luca Zanoli, clinical data manager MediData Studi e Ricerche, Modena
-
Alessandra Manfredi, clinical operation specialist MediData Studi e Ricerche, Modena, Italy.
Rights and permissions
About this article
Cite this article
Colosimo, C., Morgante, L., Antonini, A. et al. Non-motor symptoms in atypical and secondary parkinsonism: the PRIAMO study. J Neurol 257, 5–14 (2010). https://doi.org/10.1007/s00415-009-5255-7
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00415-009-5255-7